Today: 29 June 2026
Browse Category

NASDAQ:BLUE 9 August 2025 - 17 August 2025

Breakthrough Cures, Big Deals, and Global Health Alerts – Biotech & Health News Roundup (Aug 16–17, 2025)

Breakthrough Cures, Big Deals, and Global Health Alerts – Biotech & Health News Roundup (Aug 16–17, 2025)

For the period August 16–17, 2025, the biotech, pharma, medical, and health sectors saw a range of significant developments worldwide. Below is a comprehensive roundup of top stories categorized by theme, complete with expert insights and source links: Each news item above includes direct source references for verification. This roundup spans clinical trial outcomes, drug approvals, industry deals, public health alerts, research breakthroughs, and policy updates from around the globe during August 16–17, 2025, keeping you up to date on the latest developments in the biotech, pharma, medical, and health sectors reuters.com ts2.tech. All signs indicate that the pace of innovation and change in healthcare remains as brisk as ever – from lab discoveries and regulatory milestones to boardroom shakeups and public health challenges – ensuring plenty more to watch in the weeks ahead.
Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

This weekend brought a flurry of significant biotech, pharmaceutical, medical, and health developments worldwide – from game-changing scientific breakthroughs to high-stakes regulatory decisions and industry shake-ups. Below is a comprehensive roundup of the major news from August 9 and 10, 2025, organized by category for easy reading. Sources: The information above is drawn from reputable sources including Reuters news reports reuters.com reuters.com, official WHO statements ts2.tech, and industry trade outlets like FiercePharma and FierceBiotech ts2.tech ts2.tech. Key developments are hyperlinked to their original sources for readers who wish to delve deeper into each story. All content has been fact-checked for accuracy and presented in an accessible manner for a general audience, with expert quotes included where available to provide additional insight.
Biotech & Health Bombshells: FDA Greenlights, Clinical Breakthroughs & Global Health Milestones (Aug 8–9, 2025)

Biotech & Health Bombshells: FDA Greenlights, Clinical Breakthroughs & Global Health Milestones (Aug 8–9, 2025)

with hormone therapy for metastatic prostate cancer based on positive Phase 3 data onclive.com.) Sources: Key information and quotes in this report were drawn from Reuters news wires reuters.com reuters.com, official WHO releases who.int pharmabiz.com, and industry trade outlets including Fierce Biotech/Pharma fiercepharma.com fiercepharma.com and company statements. Each development is linked to its original source for further reading.

Stock Market Today

  • SSR Mining (SSRM) Named #20 Analyst Pick in Metals Channel Index
    June 29, 2026, 2:52 PM EDT. SSR Mining Inc (SSRM) comes in as the #20 broker analyst pick on the Metals Channel Global Mining Titans Index, which tracks 50 global metals and mining names. The analyst ranking factors in commodity prices, policy and market swings. SSRM, in the precious metals group with Newmont Corp and Barrick Mining, traded down about 3.8% midday Monday. Newmont fell 1.8% and Barrick dropped 2.5% during the session. The Metals Channel index refreshes in real time and analyst order signals current and sometimes contrarian bets in mining stocks.
Go toTop